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Mucociliary clearance in the lung is the primary defense mechanism that protects the airways
from inhaled toxicants and infectious agents. The system consists of a viscoelastic mucus layer
on top of a nearly-viscous periciliary layer surrounding the motile cilia. In healthy environments,
the thickness of the periciliary layer is comparable to the cilia length. Perturbations to this system,
whether due to a genetic disorder or acquired causes, are directly linked to infection and disease. For
example, depletion of the periciliary layer is typically observed in diseases such as chronic obstructive
pulmonary disease and cystic fibrosis. Clinical evidence connects the periciliary layer depletion to
reduced rates of mucus clearance. In this work, we develop a novel computational model to study
mucociliary transport in a microfluidic channel. We systematically vary the viscoelastic properties
and thickness of the mucus layer to emulate healthy and diseased environments. We assess cilia
performance in terms of three metrics: flow transport, internal power expended by the cilia, and
transport efficiency. We find that, compared to a control case with no mucus, a healthy mucus
layer enhances cilia performance in all three metrics. That is to say, a healthy mucus layer not
only improves flow transport, resulting in better clearance of harmful substances, but it does so
at an energetic advantage to the cilia. Stiffer mucus enhances further the transport efficiency. In
contrast, in diseased environments where the periciliary layer is depleted, mucus hinders transport
and stiffer mucus leads to a substantial decrease in transport efficiency. This decrease in transport
is accompanied by an increase in the internal power needed to complete the cilia beating cycle.
Cilia failure would occur when the required power is higher than that afforded by the cilia internal
machinery. This work provides a quantitative framework for assessing cilia performance in flow
transport in healthy and diseased environments, that can be equally applied to experimental data
on cilia-driven flows. It can thus provide a tool for the diagnostic of diseases related to mucociliary
transport.
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2I. INTRODUCTION
Cilia are microscopic hairlike organelles present on many cells in the mammalian body, either in large groups on a
single cell or as solitary structures [1]. Motile groups of cilia, the focus of this work, are found on the epithelial cells
of the trachea [2–4], ependymal cells in the brain [5, 6] and cells lining the oviduct and epididymis of the reproductive
tracts [7]. They normally beat in an asymmetric pattern resulting in fluid movement and transport of particles and
cells [8]. Dysfunction in the ciliary machinery results in decreased transport rates and can lead to disease and impaired
organ function [9, 10].
In the mammalian lung for example, mucus clearance is the primary defense mechanism that protects the airways
from inhaled toxicants and infectious agents [11, 12]. Failure of mucus clearance is linked to human lung diseases such as
chronic obstructive pulmonary disease (COPD) [13–18] and cystic fibrosis (CF) [12, 19, 20]. The mucociliary clearance
system consists of two components: a viscoelastic mucus layer that traps inhaled particles and gets transported out of
the lung by cilia-generated forces, and a low-viscosity periciliary layer that facilitates the beating of cilia; see Fig. 1(a).
Great advances have been made in understanding the mechanics of ciliary transport and cilia-generated flows; see,
for example, [21–25]. However, there is a shortage of quantitative models that predict the degree of failure in mucus
transport under perturbed and diseased conditions; Fig. 1(b). Predictive airway clearance models would improve the
understanding of cilia-related lung diseases and the development of treatment therapies [26–28].
Early mathematical models of mucociliary transport date back to the work of Barton and Raynor (1967). The
authors considered the cilium to be a rigid rod that is shorter during the recovery stroke than during the effective
stroke, and approximated its effect on the surrounding fluid using “resistance" coefficients that allowed them to obtain
somewhat realistic flow rates [29]. Numerous studies were conducted thereafter, shedding more light on the mechanics
of mucociliary transport; see, for example, [2, 22, 30–35] and references therein. Most of these works consider single or
two-layer Newtonian fluids, focusing on the effects of viscosity on fluid transport. Viscoelastic properties of the mucus
were first taken into account by Ross (1971). Ross considered a Maxwell fluid propelled by a continuous “wavy wall"
and analytically solved for the fluid transport rates [36]. More recently, Smith et al. (2007) proposed a traction layer
model consisting of three layers: a periciliary layer of Newtonian fluid, a mucus layer of Maxwell fluid, and a thin
traction layer between the periciliary and mucus layers accounting for the interaction between the cilia and the mucus.
The effect of cilia beating is modeled as a time-dependent force acting on the traction layer [37]. The traction-layer
model predicts physiologically-reasonable values of mucus transport and provides great insight into the temporal and
spatial details of mucociliary flows. However, it is limited in that it cannot take into account the details of specific
cilia beating patterns. It is also limited by the Maxwell fluid assumption, which is a linear model of viscoelasticity. It
is worth noting here that the periciliary layer was generally considered as a Newtonian fluid layer, without elasticity
or other complex properties, but recent investigations suggest that this view may be too simplistic [28, 38].
In this paper, we present a mucociliary transport model consisting of two fluid layers: a mucus layer of highly
viscoelastic fluid on top of a periciliary layer of nearly viscous fluid, as in the case of biological ciliary systems [26].
We account for the viscoelastic effects using the Oldroyd-B fluid model [39]. The Oldroyd-B model, despite its
simplicity, captures the main mechanical features of viscoelastic fluids under shear conditions, that is to say, under
conditions that are reminiscent to the shearing motions produced by beating cilia. We consider a cilia beating pattern
constructed from the rabbit tracheal cilia [2]. We formulate a system of equations governing fluid-cilia interactions and
solve it numerically using the immersed boundary method. The immersed boundary method was first proposed by
Peskin (1972) to study flow around heart valves [40, 41]. Since then, it was further developed and applied successfully
to various fluid-structure interaction problems including problems involving non-Newtonian fluids [42–45]. Here, we
present a systematic study of the effects of the parameters of the mucus layer on mucociliary transport. In particular,
we vary the mucus properties and thickness to emulate a range of healthy and diseased conditions. Our findings suggest
that the mucus parameters greatly affect mucociliary transport. We conclude by discussing the significance of these
results in relation to mucociliary transport in healthy and diseased conditions, as well as the design of microfluidic
transport mechanisms for biological and artificial cilia.
II. MODEL AND METHOD
A. Problem Formulation
Consider an infinite array of cilia beating in synchrony in a narrow channel of width Ly. The cilia have length l and
are uniformly distributed on one side of the channel at a separation distance Lx as shown in Fig. 2(a). The channel
is filled with two fluid layers: a viscoelastic mucus layer of thickness Lm on top of a nearly-viscous periciliary layer of
thickness Lp, with Lp + Lm = Ly.
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FIG. 1: Healthy and diseased ciliary systems. In a healthy state, cilia lie mostly in a nearly-viscous periciliary layer, with
only the tips penetrating into the viscoelastic mucus layer. In a diseased state, the mucus is denser and thicker, submerging
the cilia in a mostly viscoelastic environment.
The cilia beating kinematics are based on experimental data of the rabbit tracheal cilia [2] and depicted in Fig. 2(b).
Mathematically, the beating kinematics can be described in a Cartesian frame (x, y) attached at the based of the
cilium using the vector representation ξc(s, t), where s is the arclength along the cilium’s centreline from its base
(0 < s < l) and t is time (0 < t < T ). The (xc, yc) components of ξc(s, t) are given by a Fourier series expansion in
t and Taylor series in s with coefficients chosen to match the experimental data. It should be noted that the cilium
length is not conserved by the coefficients reported in [2]. Here, we rescaled the coefficient to ensure the total length
of the cilium is constant at all time.
The mucus and periciliary layers are described using the Oldroyd-B model for polymeric fluids, that is to say, for
fluids consisting of a viscous fluid solvent and a polymeric elastic solute [39]. The total deviatoric stress σ = σf +σe
of the Oldroyd-B fluid consists of contributions from the Newtonian fluid solvent σf and the polymeric elastic solute
σe. The constitutive stress-strain relations are given by
σf = 2µfD(u), σe + rσ
O
e − 2µeD(u)−∇2σe = 0, (1)
where D(u) = 12 [∇u + (∇u)T ] is the strain rate tensor, r is the relaxation time of the viscoelastic fluid, (·)O ≡
∂
∂t (·) +u·∇(·)− [∇u(·) + (·)(∇u)T ] denotes the upper convected derivative, µf and µe are the viscosities of the fluid
solvent and elastic solute respectively. The relaxation time of the viscoelastic material describes the time required for
the elastic polymers in the fluid to return to equilibrium after the stress is released [39]. Informally, it could also be
understood as “the duration for which the material remembers the effect of an applied force.” Larger r means that
applied forces will remain effective for a longer time after unloading. It should be noted that the diffusion term ∇2σe
is not inherent to the constitutive relation of the Oldroyd-B model. It has been added as a regularization term with
 1 because, in its absence, the stress tensors of the Oldroyd-B model have the potential to lose smoothness in the
long-time limit [45, 46].
The equations of motion of the Oldroyd-B fluid are obtained by substituting the regularized constitutive relations
into the balance of linear momentum. To this end, one gets the modified Navier-Stokes equation:
ρ(
∂u
∂t
+ u·∇u) +∇p− µf∇2u−∇ ·σe −f = 0. (2)
Here, ρ is the fluid density, p is the pressure field and f is the body force density acting on the fluid. Eq. (2) is to be
solved in the fluid channel in conjunction with the incompressibility equation ∇ ·u = 0 and the constitutive equation
for σe from (1). The solution to this coupled system of equations should satisfy the no-slip boundary conditions at
the channel walls and along the individual cilia
u =

∂ξc
∂t
at the cilia,
0 on the channel walls: y = 0 and y = Ly.
(3)
To emulate the effect of the mucus layer on top of the periciliary layer, we consider two viscoelastic fluids of different
material properties. The mucus layer consists of a viscoelastic fluid of thickness Lm and longer relaxation time rm.
The mucus layer lies on top of a nearly-viscous periciliary fluid of thickness Lp and shorter relaxation time rp. Previous
experimental and numerical works have shown that the interface between the mucus and periciliary layers exhibits
no significant deformations under the effect of cilia beating [22, 42, 47]. We therefore assume no deformation at the
4t=0
t=T
(a) (b)
Effective stroke direction
t=T/2
Cilium spacing L
x
Computational
domain
Periciliary layer 
   thickness Lp
Cilium length  l
  Mucus layer 
   thickness L
m
Channel width
         L
y
x
y
O
FIG. 2: Model schematics. (a) an infinite array of motile cilia beating synchronously in a channel. The channel is filled with
a viscoelastic fluid of thickness Lm atop a nearly viscous fluid of thickness Lp. (b) Kinematics of rabbit tracheal cilia, based
on [2] and scaled to preserve the length of the cilium. The effective stroke is shown in dark grey and the recovery stroke in
light grey.
interface. This assumption means that only the solvent could be exchanged between the periciliary and mucus layers
but not the polymer molecules which dictate the relaxation time of the viscoelastic fluids [4, 28]. Mathematically, the
fluid velocities are continuous at the interface and the extra shear stress σe is zero, σe|y=Lp = 0.
We use the cilium length l to scale length, the beating cycle T to scale time, the total viscosity µ = µf +µe to scale
viscosity, and the ratio between the total viscosity of the fluid to the beating cycle µ/T to scale pressure. To this
end, we get three non-dimensional parameters: (i) the Reynolds number Re = ρl2/µT measures the ratio of inertial
to viscous effects and, therefore, is negligible in drag-dominant flows; (ii) the Deborah number De = r/T measures
the elastic properties of the viscoelastic fluid and takes two distinct values: Dem in the mucus layer and Dep in the
periciliary layer; and (iii) the ratio of elastic to total viscosity α = µe/µ is taken to be the same in the mucus and
periciliary layers. In non-dimensional form, Eq. (2) and the incompressibility condition are written as
Re(
∂u
∂t
+ u·∇u) +∇p− (1− α)∇2u−∇ ·σe −f = 0,
∇·u = 0.
(4)
These equations are coupled to the constitutive relations for σe from Eq. (1), which in non-dimensional form are given
by
Dep σOe + σe − 2αD(u)− ∇2σe = 0, for 0 ≤ y < Lp,
DemσOe + σe − 2αD(u)− ∇2σe = 0, for Lp ≤ y < L.
(5)
The set of Eqs. (4) and (5) reduce to the typical incompressible Navier-Stokes equations when Dep = Dem = 0, α = 0,
and  = 0.
B. Numerical Method
For viscous fluids (σe ≡ 0) and fixed boundaries, the incompressible Navier-Stokes equations (4) can be discretized
using a standard fluid solver, such as the classical fractional step method where pressure p is treated as a Lagrange
multiplier to ensure the fluid velocities satisfy the incompressibility condition [48–50]. In the case of moving boundaries,
a standard numerical method for solving Eq. (4) is the immersed boundary method (IBM) [40, 41]. IBM uses a
standard Eulerian (fixed) mesh to solve for the fluid velocity field and a Lagrangian (moving) mesh to account for the
moving boundary, here, the cilium. To communicate between these two meshes, a regularized Dirac delta function δ
is used to project the boundary forces F onto the fluid domain,
f(x, t) =
∫
C
F (ξ, t)δ(x− ξ(s, t))ds, (6)
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FIG. 3: Numerical Methods. (a) Staggered Eulerian mesh: the horizontal and vertical arrows (→, ↑) represent the discrete
velocities in x, y directions respectively. The pressure p and the normal stresses σ11,σ22 are located at the cell centers (×).
The shear stress σ12 are located at the cell corners (◦). The Lagrangian boundary points are represented by filled circles (•).
The discrete forces along the boundary are represented by thick arrows (⇒,⇑). (b) The regularized Dirac delta function
δ(x(x, y)− ξ(ξ, η)) = φ(x− ξ)φ(y − η) evaluated at the Eulerian mesh, where φ is a one-dimensional regularized Dirac delta
function. (c) Here, we use the function φ employed by Roma et al. [52].
and to project the fluid velocities u onto the moving boundary,
∂ξ(s, t)
∂t
=
∫
F
u(x, t)δ(x− ξ(s, t))dx. (7)
Here, C denotes the Lagrangian cilia boundary and F the Eulerian fluid domain. It should be emphasized that ξ and
F are the Lagrangian mesh markers and force density along C. When the motion of the boundary is unconstrained,
ξ and F are typically related via an elastic energy function E such that F (ξ, t) = ∂E/∂ξ. In this work, the cilium
C is constrained to follow prescribed beating kinematics ξc(t). A typical technique to link ξ(t) to ξc(t) is to impose
F (ξ, t) = K[ξc(t) − ξ(t)] and use large values of the stiffness parameter K to guarantee that the motion of the
boundary ξ is close to the prescribed motion ξc. However, this technique renders the equations of motion stiff and
therefore prohibits the use of large time steps.
To circumvent this difficulty, we use the one-way coupled immersed boundary method proposed in [51], where
the boundary forces F are treated as a Lagrange multiplier to ensure that the no-slip conditions ξ = ξc at the
cilia are satisfied. This method solves for the boundary forces F implicitly with no need for additional constitutive
relationship between ξ and F . The one-way coupled immersed boundary method is comparable in temporal stability
to the classical fractional step method, thus enabling simulations with larger time steps [51].
We embed a viscoelastic solver for the Oldroyd-B fluid Eqs. (4,5) in the one-way coupled immersed boundary
method. To this end, we discretize the doubly-periodic fluid domain F = [0, Lx] × [0, Ly] using a uniform, finite-
volume, staggered Eulerian mesh, of mesh size h. Details of the staggered mesh are shown in Fig. 3(a). At each time
step, we explicitly update the elastic stress tensors σe in (5) using a standard second-order Runge-Kutta scheme.
Then, we substitute the updated stress tensors in the momentum equation (4) to update the flow field u, subject to
the incompressibility condition ∇ · u = 0 and no-slip boundary conditions (3) using a fractional step method. In (4),
we discretize the convective term u · ∇u using the explicit second-order Adams-Bashforth scheme and the diffusion
term ∇2u using the implicit Crank-Nicolson scheme. The temporal and spatial discretization of equations (3) and (4)
yields an algebraic system of equations for the fluid velocity u.
The cilium base point is located at (x, y) = (Lx/2, 0) and the effective stroke is pointing in the positive x-direction
as shown in Fig. 2(b). We use the mesh size d = h to discretize the cilium, as recommended by [51] to ensure no
penetration of streamlines. To communicate between the fluid domain and the moving cilia boundary, i.e., between
the Eulerian and Lagrangian meshes, we discretize the Dirac delta function in (6) and (7) using the discrete Dirac
delta function developed by Roma et al. [52] and illustrated in Figs. 3(b) and (c). The forces F and fluid velocity u
are updated simultaneously at each time step.
We let the fluid domain F be of size Lx × Ly = [0, 2] × [0, 2], and we set the total integration time to be 20 cilia-
beating cycles. The numerical values of the mesh sizes h = d = 0.0156 and the timestep ∆t = 2 × 10−5 are chosen
so that the solution changes little under further spatial and temporal mesh refinement. In particular, a decrease in
the spatial and temporal mesh size by a factor of 2 yields changes in the terminal cilia-driven flow rate of about 5%
(under spatial mesh refinement) and 1% (under temporal mesh refinement), see Fig. 4. Therefore, we consider the
discretization scheme to have numerically converged.
In all our simulations, we set the Reynolds number to be Re = 0.1, the elastic viscosity fraction α = 0.5, and the
Oldroyd-B regularization parameter  = 0.05. We consider a small Deborah number Dep = 0.05 of the periciliary layer
(nearly Newtonian) and we vary the elastic properties Dem of the mucus layer and its thickness Lm, which implies a
change in the thickness of the periciliary layer Lp.
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FIG. 4: Numerical Convergence. (a) The flow rate within the 20th cycle. (b) The mean flow rate as a function of cycles.
The Deborah number of the mucus layer is Dem = 5, the periciliary layer thickness is Lp = 0.8. ‘−’: h = 0.0156,
∆t = 2× 10−5; ‘×’: h = 0.0312, ∆t = 2× 10−5; ‘◦’: h = 0.0156, ∆t = 4× 10−5.
III. RESULTS
We consider two states of periciliary layer thickness: Lp = 0.8, which we label as a “healthy" state because it is
comparable to the average length of the cilium over its beating cycle as observed experimentally in healthy ciliary
systems, and Lp = 0.4, which we label as a “diseased" state. In the healthy state, the cilium tip penetrates into the
mucus layer during the effective stroke as it pushes the mucus forward while the whole cilium moves in the periciliary
layer during the recovery stroke. In the diseased state, the mucus layer covers part of the cilium at all times, even
during the recovery stroke.
Fig. 5 shows the contour plots of the elastic stress energy in these two states for mucus Deborah number Dem = 5.
The elastic stress energy is equal to the trace of the extra stress tensor tr(σe). Because the mucus layer has a longer
relaxation time than the periciliary layer, the cilium in the diseased state generates higher fluid stresses (about 10
times) compared to the cilium in the healthy state. The spatial distribution of the elastic stress energy is also different
in the two states. During the effective stroke, the stress is distributed along the cilium in the healthy state, while in
the diseased state it is concentrated close to the cilium tip. During the recovery stroke, we observe larger regions of
high stress with slower decay rate in the diseased state compared to the healthy state. We next examine the effects
of the elastic stress in the mucus on the fluid velocity field in both the health and diseased environments.
A. Cilia-driven Fluid Velocity
Figs. 6(a) and (b) depict the flow fields of the cilium in the healthy and diseased states respectively. The fluid
velocities close to the cilium are dictated by the cilium motion because of the no-slip boundary conditions. However,
the decay of the flow velocities over space is affected by the elastic stress distribution. Compared to the healthy state,
the velocities decay slower in the diseased state because of the high level of stress energy. The velocity differences
between the two states ∆u = udiseased − uhealthy are shown in Fig. 6(c). It shows an increase in positive flow
during the effective stroke and an increase in negative flow during the recovery stroke, with the maximum difference
in velocity appearing above the tip of the cilium. This instantaneous picture is not sufficient to assess the overall
velocity difference between the healthy and diseased states. For that, we evaluate the time averaged flow fields over
one beating cycle, as discussed next.
Fig. 7(a) shows the time averaged flow fields 〈u〉 = 1T
∫ T
0
udt. In the healthy state, the velocity field averaged over
one cycle shows a single vortex-like structure below the cilium tip. On the other hand, 〈u〉 in the diseased state shows
two counter-rotating vortex-like structures. Particularly, the vortex structure at the front end (left) of the cilium
rotates counter-clockwise, generating a back flow above the cilium tip in this location. It is peculiar that the healthy
state favors an asymmetric flow structure while the diseased state is characterized by a symmetric flow. Symmetry
here is detrimental to net flow and transport in the direction of the effective stroke.
We further average the velocity field in the x-direction, namely, we compute 〈ux〉 = 1Lx
∫ Lx
0
〈u〉 ·exdx, with ex being
the unit vector pointing to the x-direction. The average velocity profiles are depicted in Fig. 7(b) and correspond to
nonlinear shear profiles. The results of a benchmark computation in which the periciliary layer takes up the entire
channel (no mucus) are shown in dashed lines. We will refer to this benchmark computation as the control case. In
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FIG. 5: Elastic stress energy. Contour plots of the stress energy tr(σe) in (a) healthy (Lp = 0.8) and (b) diseased (Lp = 0.4)
states, shown at t = 0.2T during the effective stroke and t = 0.7T during the recovery stroke. Here, Dem = 5 and Dep = 0.05.
the healthy state, the velocity 〈ux〉 is almost identical to that of the control case for y < 0.8 (periciliary layer) and
faster than that of the control state for y > 0.8 (mucus layer), with max(〈ux〉)healthy = 0.22. In the diseased state,
the flow velocity lags behind the control case for all y and, unlike the healthy and control states, the flow is negative
in the periciliary layer. The highest mean velocity in the diseases state is max(〈ux〉)diseased = 0.10, that is, max(〈ux〉)
drops by over 50% from the healthy. This drop in fluid transport can be attributed to the higher stress energy in the
diseased state, which makes the mucus layer “stiffer" and solid like, thus hindering fluid velocity and flow transport.
B. Cilia Internal Moments and Power Requirements
We now evaluate the internal moments required in order for the cilia to perform the prescribed beating kinematics
in both the healthy and diseased conditions. We assume that the beating kinematics is not affected by the thickness of
the mucus layer or its elastic properties. This assumption is useful to compare the performance of the unchanged cilia
kinematics under various mucus conditions. The internal bending moments q generated by each cilium are obtained
using the Kirchhoff model for an elastic filament as done in [53, 54], which yields q = Bt′′× t+ t× ∫ l
s
F (s˜, t)ds˜. Here,
B is the dimensionless bending rigidity of the cilium, which we set to B = 6.54×10−4 as done in [53, 54], t is the unit
tangent to the cilium and the prime superscript (·)′ represents derivative with respect to arclength s (t′′ = ∂2t/∂s2).
Fig. 8 depicts the magnitude of the internal bending moments ‖q‖ as a function of the arclength s at two snapshots
corresponding to t = 0.2T during the effective stroke and t = 0.7T during the recovery stroke. Fig. 8(a) shows the
values of ‖q‖ in the healthy state (Lp = 0.8) for four different values of Dem = 1, 2, 5, 10 compared to the control
case (no mucus, dashed line) and Fig. 8(b) compares the diseased state (Lp = 0.4, Dem = 1, 2, 5, 10) to the control
case. Interestingly, in the healthy state, the magnitude ‖q‖ of the internal moments is independent of Dem and it
takes smaller values than those in the absence of mucus (dashed line). That is to say, in the healthy state and within
the considered range of Deborah numbers, the internal moments required to perform the cilia beating kinematics
are independent of the elastic properties of the mucus; and the same cilia beating kinematics require weaker internal
moments in the presence of mucus than in its absence. The latter can be explained as a result of the interplay between
the elastic properties of the fluid and the oscillatory motion of the cilia. Elasticity causes the fluid to “react" in the
opposite direction once the applied forces are released. Therefore, at each reversal in the cilium motion from effective
to recovery stroke and vice versa, the elastic reaction of the fluid tends to reinforce the reversal in the cilium motion,
thus requiring the cilium to exert smaller forces on the fluid and resulting in smaller internal moments along the
cilium. On the other hand, in the diseased state, the required internal moments increase as a function of the mucus
80
1
2
3
4
5
0
1
2
3
4
5
0.0
0.5
1.0
1.5
2.0
0.0 0.5 1.0 1.5 2.0
Healthy state Diseased state
0.0 0.5 1.0 1.5 2.0
0.0
0.5
1.0
1.5
2.0
R
ec
o
v
er
y 
str
o
ke
Ef
fe
ct
iv
e 
st
ro
ke
y
y
x x
0
0.5
1.0
1.5
||∆u||
Difference(a) (b)
0
0.5
1.0
1.5
||∆u||
0.0 0.5 1.0 1.5 2.0
x
0
1
2
3
4
5
0
1
2
3
4
5
||u||
(c)
||u||
||u|| ||u||
Lp
Lp
FIG. 6: Velocity vector fields. Velocity fields in (a) healthy state (Lp = 0.8) and (b) diseased state (Lp = 0.4). (c) The
difference between the two vector fields. The colormap shows the magnitude of the fluid velocities. Here, Dem = 5,
Dep = 0.05.
Deborah number and exceed the internal moments of the control case at Dem = 5 and 10. In the diseased state, as
the Deborah number increases, the mucus becomes more stiff with little difference in the elastic energy between the
effective and recovery strokes (Fig. 5). This causes the system to loose the favorable interplay observed in the healthy
state between fluid elasticity and oscillatory cilia kinematics and requires higher internal moments for the cilium to
complete its beating cycle.
The average power 〈P 〉 expended internally by the cilium is equal to the power consumed by the internal moments
q. Namely, one has 〈P 〉 = 〈∫ L
0
max(0, q ·Ω)ds〉, where Ω = (‖t˙‖/‖t× t˙‖) t× t˙ is the angular velocity vector and the
dot represents derivative with respect to time (t˙ = ∂t/∂t). Negative work is not taken into account because the cilium
does not harvest energy from the ambient flow [53]. Since the internal moment required in the healthy state is lower
than that in the control case (no mucus), the resulting power is lower as well (〈P 〉 = 72.5 in the healthy state vs. 81
in the diseased state). This reduction in power requirement is consistent with the analysis of Lauga [55], where he
examined analytically the swimming motion of a small amplitude waving sheet in weakly-viscoelastic fluids. Lauga
showed that it is energetically beneficial to swim in a fluid that has some elasticity, compared to a Newtonian fluid
with the same viscosity. The power requirement in the diseased state with Dem > 8 is higher than that of the control
case. In this case, Lauga’s assumption of weak viscoelasticity is no longer valid.
C. Effects of Mucus Layer on Flow Transport, Power and Efficiency
We study the effects of the Deborah number Dem and thickness Lm of the mucus layer on the mean flow transport
〈Q〉, mean power expenditure 〈P 〉 and efficiency η of the cilia. The total flow transported by the cilia in the channel
is equal to the flow across any plane at constant x (a direct result of flow incompressibility). That is to say, the flow
rate at any given time is given by Q(t) =
∫ Ly
0
u(0, y, t) · exdy. Averaging over one cycle, we get the mean flow rate
〈Q〉 = 1T
∫ T
0
Qdt. Given 〈Q〉 and 〈P 〉, we define the cilia transport efficiency as η = µl−3〈Q〉2/〈P 〉. This definition of
efficiency is consistent with that employed in [53, 56].
We vary the Deborah number of the mucus layer Dem from 1 to 10. Fig. 9(a) shows the rate of flow transport as a
function of the Deborah number for four distinct values of the periciliary layer thickness: Lp = 0.4, 0.6, 0.8 and 1. The
values of Lp = 0.4 and 0.6 correspond to diseased conditions where the mucus layer penetrates into the periciliary
space. Evidently, the effects of the mucus elasticity depends highly on the thickness of the mucus layer. Higher
elasticity increases the flow rate in the healthy states while decreases the flow rate in the diseased states. The flow
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FIG. 7: Flow velocity averaged over one cilia beating cycle. (a) Mean velocity fields over one beating cycle. The closed loops
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dashed curves represent the flow profile of a control state where there is no mucus (Lp = 2.0). The light grey dashed lines
denote the interface between the mucus/periciliary layers.
rates of the healthy states are higher than the control case (no mucus, dashed line) while those of the diseased states
are lower. In fact, the flow rate of the diseased state Lp = 0.4 is only 20% of the healthy flow rates at Dem = 10.
These findings are consistent with the results of Teran et al. [43], where they showed that compared to the viscous
case, elasticity can be beneficial to the swimming of a sperm cell for a range of Deborah number and detrimental to
the swimming motion if the Deborah number is too high. Further, Fig. 9(a) also shows that for a given thickness of
the periciliary layer, the flow rates plateau for Dem ≈ 10, suggesting that the transport performance is robust to
further changes in viscoelastic properties of the mucus layer.
The mean power 〈P 〉 expended by the cilium in one cycle is depicted in Fig. 9(b). Clearly, for Lp ≥ 0.6 the power
expenditure is almost independent of the mucus Deborah number. However, for Lp = 0.4, the power requirement
increases with Dem. That is to say, the thinner periciliary layer Lp = 0.4 is characterized not only by a lower flow rate
〈Q〉 but also by a higher power requirement. Therefore, when limited by the energy budget of cilia in real biological
system 〈P 〉cr, cilia may not be able to complete the beating cycle once the required power exceeds that budget.
Without access to the energy budget of biological cilia, we assume that the cilia have enough power to complete
the prescribed beating cycle and compute the transport efficiencies (see Fig. 9(c)). The curves exhibit similar trends
as the flow rates 〈Q〉. In the healthy states, higher efficiencies are observed for higher Deborah numbers. In the
diseased states, the efficiencies decrease with increasing Deborah numbers. In particular, at Dem = 10, the efficiency
of Lp = 0.4 is only 5% of the efficiency of Lp = 0.8. We further plot the values of Lp that maximize 〈Q〉 and η versus
the mucus Deborah number Dem in Fig. 9(d). Clearly, the optimal Lp increases from 0.6 to 0.9 as Dem increases from
1 to 10 but at a decreasing rate of change for larger Dem. That is to say, for larger Dem, the optimal periciliary layer
thickness seems to level off and is not very sensitive to the further changes in Dem.
Finally, we highlight the dependence of the performance metrics 〈Q〉, 〈P 〉 and η on the thickness Lp of the periciliary
layer for a fixed value of Dem = 10. The flow rate 〈Q〉 is not a monotonic function of Lp (Fig. 9(e)). It is largest
for Lp = 0.87, for which the efficiency η is also largest (Fig. 9(h)). That is, Lp = 0.87 is the optimal value of the
periciliary layer thickness. This value is close to the value Lp = 0.8, which we labeled as healthy state, where the
thickness of the periciliary layer is comparable to the average cilia length. On the other hand, the required power
reduces gradually when Lp decreases from 1 to 0.6, but increases sharply when Lp < 0.6 (see Fig. 9(f)). An increase
in the mucus layer Lm and a decrease in the periciliary thickness Lp may require higher powers than those affordable
by the cilia, thus preventing the cilia from completing their beating cycle, leading to decreased transport performance
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functions of periciliary layer thickness Lp for Dem = 10. Results are interpolated by cubic spline functions. Grey vertical lines
show the periciliary layer thicknesses with the highest flow rate and transport efficiency. 〈P 〉cr represents the (presumed)
energy budget of cilia.
and even complete failure in their transport function, as observed in lung diseases including CF and COPD.
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IV. DISCUSSION
Mucociliary clearance in the lung serves to effectively transport inhaled toxic molecules and undesirable particles
away from the tissue surfaces, thus shielding the airways from potentially infectious agents. Disruptions in the ciliary
apparatus, whether due to a genetic disorder or acquired causes, are directly linked to infection and disease such as
CF and COPD. In these diseased conditions, the mucociliary system is characterized by a depletion of the watery
periciliary layer underlying the mucus layer. Clinical evidence connects the periciliary layer depletion to reduced rates
of mucus clearance [12, 57]. In fact, in vivo analyses of wild-type (healthy) and CF murine nasal airway surface liquid
thickness show that CF decreases the airway surface liquid height from 7µm to 4µm, with periciliary layer thickness
decreased almost by half from 4µm to 2.5µm [38].
In this work, we developed a novel computational model to study mucociliary transport in a microfluidic channel
consisting of a mucus layer (viscoelastic fluid) atop a periciliary layer (nearly-viscous fluid). We systematically
varied the viscoelastic properties and thickness of the mucus layer to emulate healthy and diseased conditions. The
representative diseased state has a periciliary layer thickness half of the representative healthy state, which is consistent
with experimental observations [38]. We assessed cilia performance in terms of three metrics: flow transport, internal
power expended by the cilia, and transport efficiency. We found that, compared to a control case with no mucus, a
healthy mucus layer enhances cilia performance in all three metrics. That is to say, a layer of mucus atop a healthy
periciliary layer not only improves flow transport but it does so at an energetic advantage for the cilia. Further, in
healthy environments, increasing the Deborah number of the mucus layer enhances transport efficiency. In contrast,
in diseased environments where the periciliary layer is depleted, mucus hinders transport and larger Deborah numbers
reduce transport efficiency further. This decrease in efficiency is accompanied by an increase in the internal torques
and power needed to complete the cilia beating cycle. Cilia therefore may not be able to beat at all if the required
power is higher than the power afforded by the cilia internal machinery - this is consistent with clinical observations
that link thin periciliary layers to cilia failure and dysfunction [57]. It is worth noting here that the transport efficiency
we obtained in the diseased state of a depleted periciliary layer Lp = 0.4 is only 5% of the value of the transport
efficiency obtained in the healthy state of a periciliary layer thickness Lp = 0.8. This decrease in performance in
the diseased state is accompanied by larger elastic stresses at the cilia tips and by two counter-rotating vortex-like
structures below the cilia tips. The symmetry of these dipolar vortex structures is detrimental to net transport.
Our modeling framework systematically couples mucociliary transport to the parameters of the mucus layer. It
establishes variations in the flow transport in response to perturbations in the mucus and periciliary layers, regardless
of the physiological mechanisms that bring this about. Here, a few comments on the model advantages and limitations
are in order:
(i) Our underlying assumption throughout this work was that the beating kinematics is not affected by the thickness of
the mucus layer or its elastic properties. This framework is useful to compare the performance of the unchanged cilia
kinematics under various mucus conditions. We found that cilia performance is enhanced in the presence of a healthy
mucus layer than in the control case of no mucus, and diminished in diseased environments when the periciliary layer
is depleted. A future extension of the present study would be to allow the cilia beat kinematics to change dynamically
in response to changes in the mucus environment. Such complementary approach would provide valuable insights into
the effects of diseased environments on changes in the cilia beating patterns.
(ii) All cilia in this study are beating in synchrony, as ensured by the periodic boundary conditions in the x-direction.
In reality, cilia beat in an orchestrated metachronal wave. In a previous work that does not explicitly account for the
mucus layer, we showed that compared to beating in synchrony, a metachronal beat can result in as much as 6 times
higher flow velocity for this particular cilia beating pattern [54]. Taking this as a guideline, we scale the dimensionless
average flow rate in the healthy condition 〈Q〉/Ly = 0.09 by the characteristic length lc = 6 × 10−6 m and time
tc = 1/15 s reported in [2] for the cilia beating pattern we considered in this study. The resulting estimate of the flow
rate under healthy conditions is about 48.6 µm/s in our model. Our estimate is congruent with the estimate obtained
in [37] and shows good agreement to various experimental measurements. In particular, experimental flow rates in
the range 70−92 µm/s were reported in [58] for tracheal transport of healthy subjects and in the range 67−333µm/s
in [59] using less invasive measurement technique which yield lower flow rates. More recently, a flow rate of 39.2µm/s
was reported in [60].
(iii) Mucus layers are characterized by large Deborah numbers, of order 10 − 100 in healthy environments and even
larger in diseased states [55, 61]. Here, we varied the Deborah number Dem from 1 to 10 to establish a trend of how
performance depends on Dem. We found that, in healthy environments, the transport rates increase with increasing
Dem and reach a plateau as Dem approaches 10, whereas under diseased conditions, the transport rates decrease with
increased Dem before reaching their plateau value (Fig. 9). We also found that the internal moments along the cilia
are not very sensitive to Dem under healthy conditions, but sharply increase with Dem when the periciliary layer is
depleted. These findings justify the choice of the range of Dem considered in this study. In the future, larger Dem
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will be considered, which will render the system of equations “stiff" and more challenging to solve computationally,
requiring the use of a fully implicit fluid solver.
(iv) Our results are based on two-dimensional (2D) computations and 2D cilia beating kinematics. We used this
2D set-up to better illustrate the main ideas and for easier visualization of the resulting flows. In this set-up, a
cilium should be thought of as a “wall" of synchronously beating cilia in the third z-direction (perpendicular to the
(x, y)-plane). It is worth noting that the computational framework we used is general and can be easily extended to
include 3D cilia beating patterns, albeit at an increased computational cost.
The two main results obtained from this study – the fact that a healthy mucus layer enhances the performance
of mucociliary systems and that a depleted periciliary layer can be directly linked to diminished transport and cilia
dysfunction through excessive demands on cilia internal moments – serve to complement ongoing research on under-
standing cilia-related diseases and to direct future studies. In conjunction with its role in understanding cilia-related
diseases, the quantitative model we presented in this work could play important roles in the design and use of mi-
crofluidic devices in health-related cilia research. Indeed, a novel and exciting research direction in in vitro cell
cultures lies in the development of engineered ciliated tissues in microfluidic chips, so called ‘organs-on-chips’, as the
next-generation platforms for basic research, drug development, and diagnostics [62]. Traditionally, the clinical use
of in vitro cell cultures in health-related research on respiratory tissues and mucociliary transport [27, 63] has been
mostly qualitative and lacking a direct translation to clinical readouts. Organs-on-chips aim to provide clinically rele-
vant metrics of ciliated tissue health by recapitulating and quantifying essential structure-function relationships [64],
thereby achieving better predictions of disease mechanisms and treatment options in humans compared to traditional
cell culture and animal models [65, 66]. Our three quantitative measures of cilia transport performance can be applied
to experimental data obtained from cilia-on-chip systems, thus opening the door to direct quantitative comparisons of
in-vitro healthy and diseased cilia conditions. Quantitative models such as the one presented here will be important
tools for understanding the link between tissue-engineered ciliated organs and functional outcomes.
Another future direction of this work that is directly relevant to infectious disease of the airways is to determine
what is required by a beneficial or pathogenic bacterial cell that colonizes the airway surfaces to resist or to work
within the healthy environment of mucociliary clearance. Clearly to successfully colonize the ciliated surface, such
cells must have developed mechanisms to avoid mucociliary clearance. Most research has focused on the chemical
properties of the bacteria-tissue interactions, see, e.g., [67] and references therein, whereas several recent studies in
biofluid mechanics have considered bacterial motility in otherwise still viscoelastic environments [43, 45, 55, 68, 69].
However, the mechanical strategies employed by motile bacterial cells in complex environments such as in healthy
and diseased mucociliary clearance remain an open research problem.
Finally, we note that in addition to their importance in clinical applications, the efficiency of biological cilia in
pumping and mixing fluids at very small scales provided an attractive paradigm for fluid manipulation by artificial
cilia at the micron scale [70–73]. Also, self-propelled microrobots by flagellar or ciliary activities are being proposed
as revolutionary devices in the field of minimally invasive medicines [74, 75]. The quantitative model we presented in
this study for assessing cilia performance in complex environments could serve as an important design tool in such
microfluidic applications.
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